Blood Coordinating Program

The Department of Health and Community Services has established a Provincial Blood Coordinating Program which will contribute to ensuring that blood and blood related products are utilized in a safe and efficient manner. The Provincial Blood Coordinating Program was created in December 2005 to provide leadership and collaboration with the Regional Integrated Health Authorities and Canadian Blood Services to ensure blood products will be managed safely and effectively for all health care recipients.

What We Do

The Provincial Blood Coordinating Program Office:

Serves as liaison between the Regional Integrated Health Authorities (RHA) and the Provincial Government regarding Blood Product Management.
Acts as facilitator in the development of Quality Systems with the objective to meet compliance requirements set out in the CSA Z902-04 Blood and Blood Components Standards.
Acts as Chair/Co-chair on the Provincial Blood Reference Group.
Participates as a member of the Transfusion Committees for the Regional Health Authorities when requested.
Acts as coordinator to collect data on the utilization of Intravenous Immune Globulin (IVIG) within the province, compile data received and liaise with the IVIG Atlantic Collaborative Working Group to compile reports on utilization.
Is a member of the National Technical Working Group for the Public Health Agency of Canada’s Transfusion Transmitted Injuries Surveillance System (TTISS) program.
Acts as facilitator in the implementation of the TTISS program in conjunction with Health Canada.
Participates in data submission to both the Public Health Agency of Canada TTISS Working Group and the Atlantic Collaborative Working Group for the appropriate programs.

^ Top of Page

Mission / Vision

The mission of the Provincial Blood Coordinating Program is to support through leadership and collaboration, the delivery of a safe and cost effective Transfusion Medicine Program for patients within the Provincial Health Care System.

The Vision of the Program is:

to establish and maintain a program to optimize the utilization of blood products and their alternatives;
to establish and maintain a surveillance program for adverse reactions and major errors related to transfusion medicine; and
ensure Standards for Blood and Blood Components are implemented and maintained throughout the province as it relates to blood transfusion therapy.

^ Top of Page